Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgery | 12 | 2021 | 682 | 2.160 |
Why?
|
Intracranial Aneurysm | 27 | 2023 | 1271 | 1.660 |
Why?
|
Subarachnoid Hemorrhage | 17 | 2020 | 1024 | 1.080 |
Why?
|
Endovascular Procedures | 9 | 2021 | 2216 | 0.980 |
Why?
|
Colloid Cysts | 2 | 2020 | 6 | 0.920 |
Why?
|
Vasospasm, Intracranial | 2 | 2020 | 207 | 0.760 |
Why?
|
Nicardipine | 1 | 2020 | 59 | 0.700 |
Why?
|
Carotid Artery Injuries | 2 | 2022 | 96 | 0.680 |
Why?
|
Verapamil | 1 | 2020 | 242 | 0.670 |
Why?
|
Aneurysm, Ruptured | 4 | 2018 | 455 | 0.650 |
Why?
|
Brain Ischemia | 17 | 2021 | 3007 | 0.630 |
Why?
|
Intracranial Arteriovenous Malformations | 6 | 2020 | 360 | 0.600 |
Why?
|
Hydrocephalus | 2 | 2020 | 768 | 0.560 |
Why?
|
Arterial Occlusive Diseases | 8 | 2021 | 744 | 0.560 |
Why?
|
Athletic Injuries | 5 | 2014 | 1245 | 0.530 |
Why?
|
Vasodilator Agents | 1 | 2020 | 990 | 0.510 |
Why?
|
Blood Vessel Prosthesis | 2 | 2015 | 956 | 0.490 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 141 | 0.490 |
Why?
|
Cerebral Hemorrhage | 7 | 2022 | 2655 | 0.470 |
Why?
|
Ischemic Attack, Transient | 11 | 2005 | 877 | 0.460 |
Why?
|
Thrombectomy | 5 | 2021 | 676 | 0.460 |
Why?
|
Accreditation | 1 | 2017 | 476 | 0.450 |
Why?
|
Certification | 1 | 2017 | 420 | 0.440 |
Why?
|
Cerebral Angiography | 16 | 2022 | 1264 | 0.420 |
Why?
|
Cerebral Revascularization | 4 | 2006 | 260 | 0.400 |
Why?
|
Neurosurgical Procedures | 7 | 2020 | 2076 | 0.390 |
Why?
|
Sports Medicine | 1 | 2014 | 239 | 0.390 |
Why?
|
Wounds, Nonpenetrating | 4 | 2022 | 807 | 0.360 |
Why?
|
Spinal Cord | 2 | 2017 | 1811 | 0.360 |
Why?
|
Spinal Cord Neoplasms | 2 | 2010 | 263 | 0.360 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 58 | 0.350 |
Why?
|
Cerebral Arteries | 7 | 2000 | 488 | 0.340 |
Why?
|
Hemangioma, Cavernous | 1 | 2010 | 107 | 0.340 |
Why?
|
Schools, Medical | 1 | 2016 | 883 | 0.330 |
Why?
|
Estradiol | 12 | 2005 | 1951 | 0.330 |
Why?
|
Carotid Artery, Internal | 5 | 2021 | 440 | 0.310 |
Why?
|
Ophthalmic Artery | 3 | 2005 | 57 | 0.300 |
Why?
|
Spinal Injuries | 3 | 2006 | 300 | 0.300 |
Why?
|
Neuroprotective Agents | 8 | 2011 | 958 | 0.300 |
Why?
|
Cerebrovascular Trauma | 2 | 2018 | 21 | 0.290 |
Why?
|
Faculty, Medical | 1 | 2016 | 1226 | 0.290 |
Why?
|
Stroke | 5 | 2022 | 9755 | 0.290 |
Why?
|
Cerebral Arterial Diseases | 2 | 2021 | 82 | 0.280 |
Why?
|
Infarction, Middle Cerebral Artery | 7 | 2006 | 486 | 0.270 |
Why?
|
Basilar Artery | 3 | 1998 | 207 | 0.270 |
Why?
|
Stents | 3 | 2022 | 3195 | 0.260 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2420 | 0.250 |
Why?
|
Craniotomy | 3 | 1998 | 736 | 0.250 |
Why?
|
Specialization | 2 | 2004 | 779 | 0.240 |
Why?
|
Meningitis, Fungal | 1 | 2023 | 3 | 0.230 |
Why?
|
Governing Board | 1 | 2004 | 50 | 0.220 |
Why?
|
Lumbar Vertebrae | 5 | 2009 | 1885 | 0.220 |
Why?
|
Brain Edema | 3 | 2018 | 601 | 0.220 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2023 | 38 | 0.220 |
Why?
|
Brain Injuries | 1 | 2014 | 2057 | 0.200 |
Why?
|
Heat Stroke | 1 | 2002 | 29 | 0.200 |
Why?
|
Autonomic Nerve Block | 1 | 2003 | 82 | 0.200 |
Why?
|
Astrocytoma | 2 | 2022 | 774 | 0.200 |
Why?
|
Methylprednisolone | 1 | 2023 | 386 | 0.200 |
Why?
|
Organizational Objectives | 1 | 2004 | 426 | 0.200 |
Why?
|
Internship and Residency | 3 | 2021 | 5953 | 0.190 |
Why?
|
Quality Improvement | 1 | 2017 | 3857 | 0.190 |
Why?
|
Humans | 88 | 2023 | 768166 | 0.190 |
Why?
|
Cerebrovascular Disorders | 2 | 1999 | 1485 | 0.190 |
Why?
|
Clinical Competence | 1 | 2017 | 4858 | 0.190 |
Why?
|
Science | 1 | 2004 | 236 | 0.180 |
Why?
|
Professional Competence | 1 | 2004 | 430 | 0.180 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 107 | 0.180 |
Why?
|
Surgical Instruments | 3 | 2015 | 381 | 0.170 |
Why?
|
Carotid Stenosis | 2 | 2006 | 859 | 0.170 |
Why?
|
Middle Cerebral Artery | 5 | 2023 | 271 | 0.170 |
Why?
|
Infusions, Intra-Arterial | 1 | 2020 | 220 | 0.170 |
Why?
|
Intracranial Hypertension | 1 | 2022 | 191 | 0.170 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 2080 | 0.170 |
Why?
|
Anterior Cerebral Artery | 3 | 2021 | 50 | 0.170 |
Why?
|
Reperfusion Injury | 5 | 2005 | 1039 | 0.170 |
Why?
|
Efficiency, Organizational | 1 | 2004 | 697 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2020 | 332 | 0.160 |
Why?
|
Blood Coagulation Disorders | 1 | 2022 | 350 | 0.160 |
Why?
|
Credentialing | 1 | 2019 | 114 | 0.160 |
Why?
|
Evoked Potentials, Somatosensory | 3 | 1991 | 246 | 0.160 |
Why?
|
Treatment Outcome | 16 | 2022 | 65371 | 0.160 |
Why?
|
Middle Aged | 42 | 2023 | 223492 | 0.150 |
Why?
|
Research Design | 1 | 2014 | 6211 | 0.150 |
Why?
|
Female | 64 | 2023 | 397192 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4598 | 0.150 |
Why?
|
Angioplasty, Balloon | 1 | 2022 | 592 | 0.150 |
Why?
|
Aneurysm | 2 | 2015 | 343 | 0.150 |
Why?
|
Embolization, Therapeutic | 2 | 2021 | 1402 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 16 | 2022 | 20760 | 0.140 |
Why?
|
Estrogens | 3 | 2002 | 1536 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 590 | 0.140 |
Why?
|
Consensus | 2 | 2017 | 3212 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10399 | 0.140 |
Why?
|
Pons | 1 | 1998 | 242 | 0.140 |
Why?
|
Behavior, Animal | 1 | 2004 | 1862 | 0.140 |
Why?
|
Trauma Severity Indices | 1 | 2018 | 479 | 0.130 |
Why?
|
Mesencephalon | 1 | 1998 | 338 | 0.130 |
Why?
|
Cerebellum | 2 | 2002 | 1522 | 0.130 |
Why?
|
Male | 54 | 2023 | 364719 | 0.130 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.130 |
Why?
|
Vascular Surgical Procedures | 3 | 2015 | 1506 | 0.130 |
Why?
|
Melatonin | 2 | 2013 | 670 | 0.130 |
Why?
|
Epilepsy | 1 | 2011 | 3327 | 0.130 |
Why?
|
Medicine | 1 | 2004 | 945 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1165 | 0.120 |
Why?
|
Brain Stem | 2 | 2020 | 859 | 0.120 |
Why?
|
Disease Progression | 4 | 2020 | 13671 | 0.120 |
Why?
|
Stem Cells | 2 | 2005 | 3537 | 0.120 |
Why?
|
Porosity | 1 | 2015 | 352 | 0.120 |
Why?
|
Florida | 1 | 2016 | 417 | 0.120 |
Why?
|
Brain Neoplasms | 4 | 2022 | 9118 | 0.120 |
Why?
|
Adult | 32 | 2023 | 223646 | 0.120 |
Why?
|
Multiple Trauma | 1 | 2017 | 369 | 0.120 |
Why?
|
Intermediate Filament Proteins | 2 | 2005 | 261 | 0.110 |
Why?
|
Cell Death | 5 | 2013 | 1679 | 0.110 |
Why?
|
History, 20th Century | 2 | 2016 | 2766 | 0.110 |
Why?
|
Temporal Bone | 1 | 1998 | 683 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 320 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 845 | 0.110 |
Why?
|
Antioxidants | 2 | 2013 | 1673 | 0.110 |
Why?
|
Carotid Artery Diseases | 2 | 1998 | 879 | 0.110 |
Why?
|
Rupture, Spontaneous | 4 | 2005 | 365 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 15 | 2005 | 8128 | 0.100 |
Why?
|
Postoperative Complications | 11 | 2009 | 15832 | 0.100 |
Why?
|
Headache | 2 | 2020 | 1263 | 0.100 |
Why?
|
Rats | 21 | 2005 | 23760 | 0.100 |
Why?
|
Cytochromes c | 2 | 2013 | 173 | 0.100 |
Why?
|
General Surgery | 1 | 2004 | 1720 | 0.100 |
Why?
|
Posterior Cerebral Artery | 1 | 2012 | 35 | 0.100 |
Why?
|
Aged | 30 | 2023 | 171504 | 0.100 |
Why?
|
Dipyrone | 1 | 2011 | 9 | 0.100 |
Why?
|
Cerebrovascular Circulation | 9 | 2007 | 2725 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2332 | 0.100 |
Why?
|
Pituitary Gland | 2 | 2011 | 634 | 0.100 |
Why?
|
Microsurgery | 2 | 2015 | 800 | 0.090 |
Why?
|
Neurons | 8 | 2011 | 9514 | 0.090 |
Why?
|
Sella Turcica | 1 | 2011 | 117 | 0.090 |
Why?
|
Endarterectomy | 4 | 1987 | 196 | 0.090 |
Why?
|
Cerebral Infarction | 4 | 2003 | 969 | 0.090 |
Why?
|
Universities | 1 | 2016 | 1005 | 0.090 |
Why?
|
Football | 2 | 2006 | 506 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 2055 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1573 | 0.090 |
Why?
|
Cerebral Veins | 1 | 2011 | 157 | 0.080 |
Why?
|
Paresis | 2 | 1989 | 177 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2536 | 0.080 |
Why?
|
Retrospective Studies | 12 | 2023 | 81762 | 0.080 |
Why?
|
Methazolamide | 1 | 2009 | 9 | 0.080 |
Why?
|
Perfusion Imaging | 2 | 2021 | 195 | 0.080 |
Why?
|
Brain | 7 | 2006 | 27360 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2020 | 12077 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2002 | 3445 | 0.080 |
Why?
|
Oculomotor Nerve | 1 | 1989 | 72 | 0.080 |
Why?
|
Ovariectomy | 6 | 2003 | 613 | 0.080 |
Why?
|
Lasers | 3 | 1987 | 952 | 0.080 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2009 | 92 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2015 | 2125 | 0.080 |
Why?
|
Carotid Artery Thrombosis | 1 | 1987 | 49 | 0.070 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 1987 | 25 | 0.070 |
Why?
|
Bromodeoxyuridine | 2 | 2005 | 310 | 0.070 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1987 | 144 | 0.070 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2011 | 359 | 0.070 |
Why?
|
Young Adult | 6 | 2022 | 60066 | 0.070 |
Why?
|
Spinal Cord Diseases | 1 | 2010 | 291 | 0.070 |
Why?
|
Blood-Brain Barrier | 2 | 2005 | 1034 | 0.070 |
Why?
|
Hypothalamic Neoplasms | 1 | 2007 | 21 | 0.070 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1987 | 64 | 0.070 |
Why?
|
Hippocampus | 3 | 2005 | 3785 | 0.070 |
Why?
|
Carotid Arteries | 3 | 1989 | 942 | 0.070 |
Why?
|
Testosterone | 3 | 2005 | 2491 | 0.070 |
Why?
|
Athletes | 1 | 2014 | 1162 | 0.070 |
Why?
|
Spondylolysis | 1 | 2006 | 46 | 0.070 |
Why?
|
Hemorrhage | 3 | 2021 | 3467 | 0.070 |
Why?
|
Eye Injuries | 1 | 1989 | 228 | 0.070 |
Why?
|
Temporal Arteries | 2 | 2023 | 155 | 0.060 |
Why?
|
Age Factors | 3 | 2020 | 18412 | 0.060 |
Why?
|
Optic Nerve Diseases | 1 | 1989 | 342 | 0.060 |
Why?
|
Vision Disorders | 2 | 1990 | 1093 | 0.060 |
Why?
|
Blood Pressure | 7 | 2006 | 8543 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9419 | 0.060 |
Why?
|
Spinal Neoplasms | 1 | 2011 | 715 | 0.060 |
Why?
|
Radiography | 6 | 2008 | 6983 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 36743 | 0.060 |
Why?
|
Neuroma | 1 | 2006 | 138 | 0.060 |
Why?
|
History, 19th Century | 1 | 2006 | 714 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2009 | 845 | 0.060 |
Why?
|
Cell Count | 2 | 2005 | 1832 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3464 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 1994 | 2176 | 0.060 |
Why?
|
Laser Therapy | 2 | 1987 | 1107 | 0.060 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2000 | 1117 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 4 | 2009 | 611 | 0.050 |
Why?
|
Adolescent | 10 | 2022 | 89169 | 0.050 |
Why?
|
Circle of Willis | 1 | 2023 | 77 | 0.050 |
Why?
|
Superior Cervical Ganglion | 1 | 2003 | 33 | 0.050 |
Why?
|
Arteriosclerosis | 2 | 2003 | 1055 | 0.050 |
Why?
|
Intraoperative Complications | 3 | 2007 | 1171 | 0.050 |
Why?
|
Estradiol Congeners | 1 | 2002 | 22 | 0.050 |
Why?
|
Disease Models, Animal | 9 | 2013 | 18349 | 0.050 |
Why?
|
Posture | 2 | 2004 | 957 | 0.050 |
Why?
|
Proestrus | 1 | 2002 | 14 | 0.050 |
Why?
|
United States | 7 | 2021 | 73039 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 4413 | 0.050 |
Why?
|
Caspase 3 | 3 | 2013 | 730 | 0.050 |
Why?
|
Angiography, Digital Subtraction | 2 | 2018 | 331 | 0.050 |
Why?
|
Craniocerebral Trauma | 1 | 2006 | 493 | 0.050 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2013 | 1481 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1104 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 9015 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2007 | 753 | 0.050 |
Why?
|
Cranial Sinuses | 1 | 2022 | 68 | 0.050 |
Why?
|
Spinal Diseases | 1 | 1987 | 561 | 0.050 |
Why?
|
Amphetamines | 1 | 2002 | 142 | 0.050 |
Why?
|
Vision, Ocular | 1 | 2005 | 458 | 0.050 |
Why?
|
Calpain | 1 | 2002 | 146 | 0.050 |
Why?
|
Estrone | 1 | 2002 | 234 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2271 | 0.050 |
Why?
|
Adamantane | 1 | 2002 | 148 | 0.050 |
Why?
|
Cohort Studies | 6 | 2021 | 41754 | 0.050 |
Why?
|
Mexico | 1 | 2023 | 769 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39348 | 0.050 |
Why?
|
Animals | 28 | 2013 | 169246 | 0.050 |
Why?
|
Risk Factors | 7 | 2020 | 74944 | 0.050 |
Why?
|
Vertebral Artery | 1 | 2022 | 185 | 0.050 |
Why?
|
Aneurysm, Infected | 1 | 1981 | 81 | 0.050 |
Why?
|
Time Factors | 7 | 2017 | 40218 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 24315 | 0.040 |
Why?
|
Hematoma | 2 | 2022 | 766 | 0.040 |
Why?
|
Awareness | 1 | 2005 | 654 | 0.040 |
Why?
|
Carotid Sinus | 1 | 1980 | 44 | 0.040 |
Why?
|
Glutamates | 1 | 2002 | 385 | 0.040 |
Why?
|
Behavioral Symptoms | 1 | 2002 | 188 | 0.040 |
Why?
|
Iatrogenic Disease | 1 | 2023 | 552 | 0.040 |
Why?
|
Creatine | 1 | 2002 | 427 | 0.040 |
Why?
|
Hypotension | 1 | 1986 | 888 | 0.040 |
Why?
|
Registries | 1 | 2016 | 8375 | 0.040 |
Why?
|
Spinal Fractures | 1 | 2006 | 710 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 637 | 0.040 |
Why?
|
Internal Capsule | 1 | 2000 | 138 | 0.040 |
Why?
|
Retreatment | 1 | 2021 | 598 | 0.040 |
Why?
|
Physician's Role | 1 | 2006 | 925 | 0.040 |
Why?
|
Spinal Fusion | 1 | 2009 | 1307 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 754 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14783 | 0.040 |
Why?
|
Vascular Patency | 1 | 2002 | 917 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 948 | 0.040 |
Why?
|
Chondroma | 1 | 1998 | 53 | 0.040 |
Why?
|
Petrous Bone | 1 | 1998 | 85 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2013 | 6229 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 1998 | 171 | 0.040 |
Why?
|
Neurotoxicity Syndromes | 1 | 2002 | 302 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4035 | 0.040 |
Why?
|
Brain Infarction | 1 | 1999 | 286 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2023 | 1120 | 0.040 |
Why?
|
Forecasting | 2 | 1999 | 2945 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2005 | 1408 | 0.040 |
Why?
|
Skull Neoplasms | 1 | 1998 | 173 | 0.040 |
Why?
|
Cavernous Sinus | 1 | 1998 | 121 | 0.040 |
Why?
|
Infant | 4 | 2018 | 36535 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5027 | 0.040 |
Why?
|
Independent Living | 1 | 2021 | 584 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15454 | 0.030 |
Why?
|
Thromboembolism | 1 | 2003 | 1004 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 1998 | 8759 | 0.030 |
Why?
|
Oligopeptides | 1 | 2002 | 1194 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2003 | 1429 | 0.030 |
Why?
|
Cerebral Cortex | 3 | 2003 | 5812 | 0.030 |
Why?
|
Monitoring, Physiologic | 3 | 1991 | 1798 | 0.030 |
Why?
|
Indoles | 1 | 2004 | 1836 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10590 | 0.030 |
Why?
|
Child | 7 | 2020 | 80917 | 0.030 |
Why?
|
Sports | 1 | 2002 | 703 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11095 | 0.030 |
Why?
|
Nicotinic Agonists | 1 | 1998 | 265 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1998 | 553 | 0.030 |
Why?
|
Mitochondria | 1 | 2009 | 3681 | 0.030 |
Why?
|
Apoptosis | 1 | 2011 | 9523 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6498 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1998 | 451 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1557 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 1998 | 462 | 0.030 |
Why?
|
Radiosurgery | 2 | 2019 | 1330 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3814 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 1998 | 494 | 0.030 |
Why?
|
Hypothalamus | 1 | 1999 | 1004 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2253 | 0.030 |
Why?
|
Patient Transfer | 1 | 2021 | 792 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2000 | 12800 | 0.030 |
Why?
|
Blood Flow Velocity | 3 | 2002 | 1375 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 1998 | 753 | 0.030 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2013 | 31 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59629 | 0.030 |
Why?
|
Hemodynamics | 1 | 2003 | 4194 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2059 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 903 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1135 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2003 | 1662 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2019 | 1273 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2007 | 13014 | 0.020 |
Why?
|
Fever | 1 | 1999 | 1614 | 0.020 |
Why?
|
Angiography | 2 | 2005 | 1597 | 0.020 |
Why?
|
Cervical Vertebrae | 2 | 2009 | 979 | 0.020 |
Why?
|
Trauma Centers | 1 | 2017 | 951 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2009 | 3590 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20227 | 0.020 |
Why?
|
Argon | 2 | 1987 | 36 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9263 | 0.020 |
Why?
|
Intracranial Arteriosclerosis | 1 | 1992 | 138 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6340 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 1992 | 216 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2017 | 1474 | 0.020 |
Why?
|
Medicare Part A | 1 | 2011 | 40 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42669 | 0.020 |
Why?
|
Median Nerve | 1 | 1991 | 133 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1397 | 0.020 |
Why?
|
Logistic Models | 2 | 2018 | 13290 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2001 | 238 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2018 | 26422 | 0.020 |
Why?
|
Neck | 1 | 2015 | 736 | 0.020 |
Why?
|
Thoracic Vertebrae | 2 | 2009 | 613 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 297 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2013 | 596 | 0.020 |
Why?
|
Intraoperative Period | 1 | 1991 | 513 | 0.020 |
Why?
|
Blood Gas Analysis | 2 | 2002 | 384 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3628 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23645 | 0.020 |
Why?
|
Melanoma | 1 | 2008 | 5706 | 0.020 |
Why?
|
Arachnoid | 1 | 1989 | 50 | 0.020 |
Why?
|
Meningioma | 1 | 1998 | 1220 | 0.020 |
Why?
|
Saphenous Vein | 1 | 1992 | 519 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4860 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 1998 | 1253 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 598 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 21538 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15948 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3402 | 0.020 |
Why?
|
Caspase 1 | 1 | 2009 | 227 | 0.020 |
Why?
|
Orchiectomy | 2 | 2002 | 466 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2009 | 412 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 185 | 0.020 |
Why?
|
Staining and Labeling | 2 | 2003 | 1081 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5536 | 0.020 |
Why?
|
Patient Care Team | 1 | 1999 | 2523 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3886 | 0.020 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2008 | 102 | 0.020 |
Why?
|
Hospital Charges | 1 | 2009 | 347 | 0.020 |
Why?
|
Fractures, Bone | 1 | 1979 | 2062 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 1998 | 2232 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 1992 | 556 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11928 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5703 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54926 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1992 | 1493 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
Diskectomy | 1 | 2007 | 203 | 0.020 |
Why?
|
Agnosia | 1 | 1986 | 67 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22291 | 0.020 |
Why?
|
Health Care Reform | 1 | 1994 | 1256 | 0.010 |
Why?
|
Laminectomy | 1 | 1986 | 226 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1989 | 520 | 0.010 |
Why?
|
Rabbits | 2 | 1987 | 4772 | 0.010 |
Why?
|
Dogs | 2 | 1986 | 3845 | 0.010 |
Why?
|
Vision Tests | 1 | 2005 | 160 | 0.010 |
Why?
|
Arteries | 2 | 2007 | 1127 | 0.010 |
Why?
|
Models, Neurological | 1 | 2012 | 1776 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 2003 | 92 | 0.010 |
Why?
|
Mice | 5 | 2013 | 82029 | 0.010 |
Why?
|
Evoked Potentials, Auditory | 1 | 1987 | 533 | 0.010 |
Why?
|
Cysts | 1 | 1989 | 685 | 0.010 |
Why?
|
Eye Diseases | 1 | 1989 | 660 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21206 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2005 | 461 | 0.010 |
Why?
|
Drug Utilization | 1 | 2009 | 1189 | 0.010 |
Why?
|
Reaction Time | 2 | 1987 | 2101 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2009 | 1027 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14729 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2005 | 394 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2005 | 633 | 0.010 |
Why?
|
Cell Survival | 2 | 2002 | 5777 | 0.010 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2005 | 423 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 4580 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22379 | 0.010 |
Why?
|
Estrogen Receptor beta | 1 | 2002 | 171 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1647 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2007 | 1015 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 30010 | 0.010 |
Why?
|
Optic Nerve | 1 | 2005 | 571 | 0.010 |
Why?
|
Drug Implants | 1 | 2002 | 230 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2002 | 1142 | 0.010 |
Why?
|
Central Nervous System | 1 | 2008 | 1346 | 0.010 |
Why?
|
Speech Perception | 1 | 1986 | 510 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4063 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9561 | 0.010 |
Why?
|
Intracranial Pressure | 1 | 1982 | 323 | 0.010 |
Why?
|
Permeability | 1 | 2002 | 725 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2009 | 1095 | 0.010 |
Why?
|
Tomography, X-Ray | 1 | 1979 | 58 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1972 | 0.010 |
Why?
|
Visual Acuity | 1 | 1989 | 2714 | 0.010 |
Why?
|
Paresthesia | 1 | 1980 | 160 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5884 | 0.010 |
Why?
|
Motor Skills | 1 | 2002 | 523 | 0.010 |
Why?
|
Caspases | 1 | 2002 | 882 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2005 | 1089 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 2002 | 581 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10101 | 0.010 |
Why?
|
Functional Laterality | 1 | 2005 | 2264 | 0.010 |
Why?
|
Cell Line | 2 | 2002 | 15597 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1986 | 1726 | 0.010 |
Why?
|
Benzylidene Compounds | 1 | 1998 | 25 | 0.010 |
Why?
|
Drug Carriers | 1 | 2002 | 709 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30238 | 0.010 |
Why?
|
Reflex | 1 | 1999 | 375 | 0.010 |
Why?
|
Sacrum | 1 | 1979 | 274 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1981 | 436 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2002 | 2474 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2002 | 749 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1998 | 2087 | 0.010 |
Why?
|
Olfactory Bulb | 1 | 1998 | 198 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1191 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12840 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2000 | 1888 | 0.010 |
Why?
|
Body Temperature | 1 | 1999 | 780 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8542 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13676 | 0.010 |
Why?
|
Blindness | 1 | 1980 | 587 | 0.010 |
Why?
|
Dinoprostone | 1 | 1998 | 597 | 0.010 |
Why?
|
Suture Techniques | 1 | 2000 | 775 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3284 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4206 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1987 | 944 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1986 | 3124 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 8509 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6329 | 0.010 |
Why?
|
Plasmids | 1 | 1998 | 2269 | 0.010 |
Why?
|
Drug Combinations | 1 | 1998 | 2089 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4627 | 0.010 |
Why?
|
Coronary Disease | 1 | 1986 | 5919 | 0.010 |
Why?
|
Morbidity | 1 | 1996 | 1755 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10760 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1996 | 1667 | 0.010 |
Why?
|
Transfection | 1 | 1998 | 5755 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1998 | 6082 | 0.000 |
Why?
|
Necrosis | 1 | 1992 | 1616 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1998 | 2650 | 0.000 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1986 | 80 | 0.000 |
Why?
|
Disabled Persons | 1 | 1996 | 1210 | 0.000 |
Why?
|
Pyridines | 1 | 1998 | 2894 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1986 | 863 | 0.000 |
Why?
|
Critical Care | 1 | 1996 | 2715 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1986 | 769 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 19015 | 0.000 |
Why?
|
Aorta | 1 | 1987 | 2045 | 0.000 |
Why?
|
Syndrome | 1 | 1986 | 3272 | 0.000 |
Why?
|
Quality of Life | 1 | 1996 | 13490 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1979 | 1281 | 0.000 |
Why?
|
Seizures | 1 | 1979 | 2998 | 0.000 |
Why?
|